06.08.2019 • NewsMerckUniversal Display CorporationR%26D

Merck KGaA and Universal Display Link on OLEDS

Germany’s Merck KGaA has signed an R&D pact with US-based Universal Display...
Germany’s Merck KGaA has signed an R&D pact with US-based Universal Display Corporation (UDC) to cooperate on developing new products and further advance OLED displays. © Oleksiy Mark/Shutterstock

German chemicals and pharmaceuticals group Merck KGaA has signed an R&D agreement with Ewing, New Jersey-based Universal Display Corporation (UDC) to cooperate on developing new products and further advancing OLED displays.

The joint development program will bring together the US company’s expertise in leading-edge phosphorescent OLED emitters and Merck’s state-of-the-art transport materials, with the goal of developing higher performing OLED stacks for OLED manufacturers worldwide.

UDC’s Universal’s PHOLED technology and materials are designed to enable energy-efficient displays and lighting.

Kai Beckmann, CEO Performance Materials and member of the Executive Board of Merck, said the two partners “bring a perfectly matching set of know-how to the table” that will “greatly support” the Darmstadt-based liquid crystals giant in supplying its customers.

New insights gained during the collaboration will also help to “further advance and increase the performance of OLED technology in general, one of the most promising fields for the display industry,” Beckmann said.

Steven V. Abramson, president and CEO of the New Jersey company, said the research pactl with Merck will “help expand the landscape of bright, beautiful, brilliant OLED displays in the marketplace.”

Under a long standing agreement dating back to 2000, UDC’s PHOLED-based products are exclusively produced by paints and coatings manufacturer PPG at its plants in Monroeville, Pennsylvania, and Barberton, Ohio, manufacturing facilities.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.